BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4086560)

  • 1. Capillary gas chromatographic determination of vincamine in plasma.
    Michotte Y; Massart DL
    J Chromatogr; 1985 Nov; 344():367-71. PubMed ID: 4086560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood levels of vincamine. Comparative study of vincamine in delayed and immediate actions].
    Balcazar de Aztegui MD; Cruz Ramirez J
    Prensa Med Mex; 1978; 43(1-2):61-3. PubMed ID: 704535
    [No Abstract]   [Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of vincamine.
    Pietta P; Rava A; Catenacci E
    J Chromatogr; 1981 May; 210(1):149-53. PubMed ID: 7251726
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of vincamine in human plasma using automated high-performance liquid chromatography.
    Dubruc C; Caqueret H; Bianchetti G
    J Chromatogr; 1981 Jan; 204():335-9. PubMed ID: 7217262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of vincamine in plasma by high-performance liquid chromatography with voltammetric detection.
    Smyth MR
    Analyst; 1986 Jul; 111(7):851-2. PubMed ID: 3752527
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of 11-bromovincamine in human plasma by high-performance liquid chromatography.
    Brodie RR; Chasseaud LF
    J Chromatogr; 1982 Mar; 228():413-7. PubMed ID: 7076771
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relative bioavailability of a vincamine retard formulation. Pharmacokinetic study in normal subjects (author's transl)].
    Erking W; Lücker PW; Metz G; Specker M; Wetzelsberger K
    Arzneimittelforschung; 1978; 28(12):2332-6. PubMed ID: 582951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatographic method for the determination of vincamine in blood.
    Kinsun H; Moulin MA
    J Chromatogr; 1977 Nov; 144(1):123-6. PubMed ID: 914956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of the in vitro availability of vincamine from delayed-release forms. 1].
    Rolland A; Gibassier D; Chemtob C; Le Verge R
    J Pharm Belg; 1984; 39(2):93-9. PubMed ID: 6470921
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative in vitro evaluation of six commercial vincamine prolonged-release dosage forms.
    Buri P; Doelker E; Boucherat J
    J Clin Hosp Pharm; 1981 Jun; 6(2):101-5. PubMed ID: 7343559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of two pharmaceutical preparations containing alkaloid vincamine administered orally to human subjects.
    Millart H; Lamiable D; Houin G; Plat M; Choisy H; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):581-6. PubMed ID: 6654533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic study of vincamine teprosilate.
    Cadórniga R; Saiz Vadillo MC; Molina IT; Cadórniga L
    Int J Clin Pharmacol Res; 1984; 4(4):281-90. PubMed ID: 6500775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic, recurrent, cervical-spine syndrome. Therapeutic observations with vincamin-depot].
    Kühle A
    ZFA (Stuttgart); 1979 Jan; 55(3):188-91. PubMed ID: 419815
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of vincamine in plasma by selected ion monitoring.
    Hoppen HO; Heuer R; Seidel G
    Biomed Mass Spectrom; 1978 Feb; 5(2):133-5. PubMed ID: 630051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolism of vincamine in the rat].
    Viganò V; Paracchini S; Piacenza G; Pesce E
    Farmaco Sci; 1978 Aug; 33(8):583-94. PubMed ID: 744256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic fate of 11-bromo[15-3H]vincamine in man.
    Mayo BC; Biggs SR; Hawkins DR; Chasseaud LF; Darragh A; Leaf FC
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):189-96. PubMed ID: 4085521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative determination of drugs by in situ spectrophotometry of chromatograms for pharmacokinetic studies. I. Sulpiride and other benzamides, vincamine, naftazone (author's transl)].
    Bressolle F; Bres J; Brun S; Rechencq E
    J Chromatogr; 1979 Jul; 174(2):421-33. PubMed ID: 546899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic action of a combination of vincamine and piracetam in peripheral labyrinthine syndromes with a vascular component].
    Jiménez-Cervantes Nicolás JA; Ferrán Bernal J; Anula Suárez P; Gil Melgarejo JA
    An Otorrinolaringol Ibero Am; 1981; 8(2):131-60. PubMed ID: 7270822
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)].
    Dany F; Merle L; Goudoud JC; Liozon F; Blanc P; Bouvot JC; Nicot G; Dangoumau J
    Therapie; 1981; 36(1):55-64. PubMed ID: 7233373
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assay and bioavailability of vincamine (author's transl)].
    Jaminet F; Schneck G; Polastro E; Lejeune A
    J Pharm Belg; 1981; 36(6):421-5. PubMed ID: 7328483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.